These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22621827)

  • 1. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation.
    Gaudiano MC; Di Maggio A; Antoniella E; Valvo L; Bertocchi P; Manna L; Bartolomei M; Alimonti S; Rodomonte AL
    J Pharm Biomed Anal; 2008 Sep; 48(2):303-9. PubMed ID: 18243626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.
    Koczwara A; Dressman J
    J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines.
    Gaudiano MC; Antoniella E; Bertocchi P; Valvo L
    J Pharm Biomed Anal; 2006 Sep; 42(1):132-5. PubMed ID: 16517111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
    Chauvé M
    C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on counterfeit drugs: a growing risk for public health].
    Juillet Y
    Bull Acad Natl Med; 2008 Oct; 192(7):1423-34; discussion 1434-6. PubMed ID: 19445366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterfeit drugs and medical devices in developing countries.
    Glass BD
    Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.
    Venhuis BJ; Keizers PH; Klausmann R; Hegger I
    Drug Test Anal; 2016; 8(3-4):398-401. PubMed ID: 26456392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public Health Implications of Counterfeit Medications.
    Fantasia HC; Vooys KM
    Nurs Womens Health; 2018 Jun; 22(3):264-268. PubMed ID: 29885715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bad medicine in the market.
    Roger B; Boateng K
    World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fingerprinting of sildenafil citrate and tadalafil tablets in pharmaceutical formulations via X-ray fluorescence (XRF) spectrometry.
    Ortiz RS; Mariotti KC; Schwab NV; Sabin GP; Rocha WF; de Castro EV; Limberger RP; Mayorga P; Bueno MI; Romão W
    J Pharm Biomed Anal; 2012 Jan; 58():7-11. PubMed ID: 22014651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substandard/counterfeit antimicrobial drugs.
    Kelesidis T; Falagas ME
    Clin Microbiol Rev; 2015 Apr; 28(2):443-64. PubMed ID: 25788516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substandard and counterfeit medicines: a systematic review of the literature.
    Almuzaini T; Choonara I; Sammons H
    BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.